$13.28 +0.36 (%) Immunogen Inc - NASDAQ

Sep. 4, 2015 | 04:00 PM

Partner Headlines

  1. Stocks Easing Off Day's Lows; Caesarstone Rebounds

    IBD | Aug. 7, 2015 | 13:00PM EST
  2. Stocks Start Little Changed; CDW Jumps On Earnings

    IBD | Aug. 3, 2015 | 10:28AM EST
  3. Benzinga's Top Downgrades

    Benzinga | Aug. 3, 2015 | 09:25AM EST
  4. Stocks Stay Near Session Highs; ImmunoGen Surges

    IBD | Jul. 16, 2015 | 14:52PM EST
  5. Stocks Hold Near Day's High; Amazon, Immunogen Break Out

    IBD | Jul. 13, 2015 | 13:25PM EST
  6. ASCO Moves Pharma Shares

    IBD | Jun. 1, 2015 | 18:52PM EST
  7. ImmunoGen Surprises, PD-1 Drugs Under Scrutiny At ASCO

    IBD | Jun. 1, 2015 | 17:48PM EST
  8. 4 Stocks Rising On ASCO Cancer Drug News

    IBD | Jun. 1, 2015 | 12:34PM EST
  9. ImmunoGen Shares Looking Healthy After Favorable IMGN853 Report

    Benzinga | Jun. 1, 2015 | 11:52AM EST
  10. Benzinga's Volume Movers

    Benzinga | Jun. 1, 2015 | 10:58AM EST
  11. Morning Market Gainers

    Benzinga | Jun. 1, 2015 | 10:16AM EST
  12. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 1, 2015 | 08:08AM EST
  13. Here's Why Oppenheimer Upgraded ImmunoGen To Outperform

    Benzinga | Feb. 6, 2015 | 10:45AM EST
  14. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 2, 2015 | 08:23AM EST
  15. Gulf Resources (GURE) Soars on Natural Gas Discovery, ImmunoGen (IMGN) and Synaptics (SYNA) ...

    GuruFocus | Jan. 31, 2015 | 20:55PM EST
  16. ImmunoGen Shares Surge 30% Following Earnings

    Benzinga | Jan. 30, 2015 | 14:16PM EST
  17. Earnings Scheduled For January 30, 2015

    Benzinga | Jan. 30, 2015 | 04:57AM EST
  18. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  19. Roche Halts Alzheimer's Trial

    IBD | Dec. 19, 2014 | 18:47PM EST
  20. Mid-Day Losers From December 19: ImmunoGen, NQ Mobile And More

    Benzinga | Dec. 19, 2014 | 13:33PM EST
  21. Juno Therapeutics IPO Caps Big Year In Biotech Deals

    IBD | Dec. 19, 2014 | 12:47PM EST
  22. Top 3 Short Ideas Among Friday's Losers

    Benzinga | Dec. 19, 2014 | 12:21PM EST
  23. Roche Drugs For Alzheimer's, Breast Cancer Disappoint

    IBD | Dec. 19, 2014 | 11:31AM EST
  24. Benzinga's Top #PreMarket Losers

    Benzinga | Dec. 19, 2014 | 09:33AM EST
  25. #PreMarket Movers From December 19, 2014: NQ Mobile, BlackBerry, CarMax And More

    Benzinga | Dec. 19, 2014 | 09:20AM EST
  26. Will ImmunoGen's Q4 Earnings Disappoint Again?

    GuruFocus | Jul. 30, 2014 | 19:21PM EST
  27. Wednesday's Biggest Movers

    Benzinga | Jun. 25, 2014 | 16:49PM EST
  28. Shares Of ImmunoGen Down On Morgan Stanley's Bearish Initiation

    Benzinga | Jun. 25, 2014 | 08:26AM EST
  29. Benzinga's Top Initiations

    Benzinga | Jun. 25, 2014 | 08:21AM EST
  30. UPDATE: Canaccord Genuity Initiates Coverage on ImmunoGen Ahead of Phase 3 Data

    Benzinga | Apr. 16, 2014 | 09:29AM EST
  31. ImmunoGen Says Initial Research Shows New Dosing Approach for IMGN853 Achieves Objective

    Benzinga | Apr. 8, 2014 | 16:17PM EST
  32. IDEXX Laboratories Elects Daniel Junius to Board of Directors

    Benzinga | Mar. 11, 2014 | 16:24PM EST
  33. US Stock Futures Down Ahead Of Wal-Mart Earnings, Economic Data

    Benzinga | Feb. 20, 2014 | 07:05AM EST
  34. CytomX Therapeutics, ImmunoGen Announce Strategic Collaboration

    Benzinga | Jan. 9, 2014 | 06:39AM EST
  35. ImmunoGen Announces Activity Reported with SAR3419 Plus Rituxan In Difficult-to-Treat Patient Population at ASH

    Benzinga | Dec. 9, 2013 | 11:31AM EST
  36. US Stock Futures Edge Lower Ahead Of FOMC Minutes, Economic Data

    Benzinga | Nov. 20, 2013 | 07:00AM EST
  37. ImmunoGen Announces Approval of Roche's Kadcyla in EU

    Benzinga | Nov. 20, 2013 | 05:56AM EST
  38. UPDATE: Morgan Stanley Downgrades ImmunoGen Following Phase 2 Failure of IMGN901

    Benzinga | Nov. 11, 2013 | 10:00AM EST
  39. Benzinga's Top #PreMarket Losers

    Benzinga | Nov. 11, 2013 | 08:19AM EST
  40. ImmunoGen Announces License Agreement with Novartis

    Benzinga | Nov. 11, 2013 | 06:38AM EST
  41. Mid-Afternoon Market Update: Marvell Rises on KKR Stake While Orbitz Gives Up Last Week's Gains

    Benzinga | Nov. 5, 2013 | 15:23PM EST
  42. Mid-Day Market Update: BroadSoft Drops On Q3 Results; Endo Health Shares Spike Higher

    Benzinga | Nov. 5, 2013 | 12:29PM EST
  43. Mid-Morning Market Update: Markets Open Lower; CVS Caremark Lifts Outlook

    Benzinga | Nov. 5, 2013 | 10:36AM EST
  44. Benzinga's Top #PreMarket Losers

    Benzinga | Nov. 5, 2013 | 08:16AM EST
  45. US Stock Futures Signal Lower Start On Wall Street

    Benzinga | Nov. 5, 2013 | 07:11AM EST
  46. ImmunoGen Presents SAR566658 Clinical Findings at AACR-NCI-EORTC Conference

    Benzinga | Oct. 20, 2013 | 17:00PM EST
  47. US Stock Futures Up; J.P. Morgan Earnings In Focus

    Benzinga | Oct. 11, 2013 | 07:13AM EST
  48. ImmunoGen Announces New License Agreement with Novartis

    Benzinga | Oct. 11, 2013 | 06:54AM EST
  49. ImmunoGen Announces Positive Results from Kadcyla Phase III Trial, TH3RESA at ECC 2013

    Benzinga | Sep. 28, 2013 | 09:23AM EST
  50. The 'L' In CANSLIM Stands For Leaders, Not Laggards

    IBD | Sep. 11, 2013 | 18:29PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!